{"id": "patient_01_q0", "query": "Which of the following is NOT part of the current treatment regimen for Mrs. Sample's DLBCL?", "options_scores": {"A": 0.00433421041816473, "B": 0.00022840518795419484, "C": 0.013483038172125816, "D": 0.7613860964775085, "E": 0.0006411497597582638}, "ranked_options": [{"letter": "B", "text": "Rituximab", "avg_nll": 0.00022840518795419484}, {"letter": "E", "text": "Doxorubicin", "avg_nll": 0.0006411497597582638}, {"letter": "A", "text": "Polatuzumab vedotin", "avg_nll": 0.00433421041816473}, {"letter": "C", "text": "Cyclophosphamide", "avg_nll": 0.013483038172125816}, {"letter": "D", "text": "Vincristine", "avg_nll": 0.7613860964775085}], "correct_answer_letter": "D", "error": null, "method": "local"}
{"id": "patient_01_q1", "query": "In the context of Mrs. Sample's other diagnoses, which of the following is NOT accurate based on the provided information?", "options_scores": {"A": 2.7859508991241455, "B": 0.5712918043136597, "C": 0.9233946800231934, "D": 1.6153630018234253, "E": 2.337549924850464}, "ranked_options": [{"letter": "B", "text": "She was diagnosed with primary progressive type of multiple sclerosis.", "avg_nll": 0.5712918043136597}, {"letter": "C", "text": "She has a mood disorder.", "avg_nll": 0.9233946800231934}, {"letter": "D", "text": "She has 3-vessel CHD.", "avg_nll": 1.6153630018234253}, {"letter": "E", "text": "She has pre-existing ALS.", "avg_nll": 2.337549924850464}, {"letter": "A", "text": "She has 2-vessel disease", "avg_nll": 2.7859508991241455}], "correct_answer_letter": "D", "error": null, "method": "local"}
{"id": "patient_01_q2", "query": "Which chronic, neuroinflammatory disease does Mrs. Sample suffer from? ", "options_scores": {"A": 7.1123857498168945, "B": 2.441559314727783, "C": Infinity, "D": 3.769212245941162, "E": 0.10013171285390854}, "ranked_options": [{"letter": "E", "text": "Autoimmune encephalitis", "avg_nll": 0.10013171285390854}, {"letter": "B", "text": "Dementia", "avg_nll": 2.441559314727783}, {"letter": "D", "text": "Brain abscess", "avg_nll": 3.769212245941162}, {"letter": "A", "text": "Multiple sclerosis", "avg_nll": 7.1123857498168945}, {"letter": "C", "text": "Parkinson", "avg_nll": null}], "correct_answer_letter": "A", "error": null, "method": "local"}
{"id": "patient_01_q3", "query": "Mrs. Sample takes Fingolimod. What is the dosis and when does the patient take it?", "options_scores": {"A": 1.7252854108810425, "B": 1.2805300951004028, "C": 2.078073501586914, "D": 2.8445608615875244, "E": 2.754331588745117}, "ranked_options": [{"letter": "B", "text": "0.5 mg, 1 capsule at bedtime", "avg_nll": 1.2805300951004028}, {"letter": "A", "text": "0.5 mg, 1 capsule in the morning", "avg_nll": 1.7252854108810425}, {"letter": "C", "text": "50 mg, 1 capsule in the morning", "avg_nll": 2.078073501586914}, {"letter": "E", "text": "70 mg, 1 capsule in the morning", "avg_nll": 2.754331588745117}, {"letter": "D", "text": "35 mg, 1 capsule at bedtime", "avg_nll": 2.8445608615875244}], "correct_answer_letter": "B", "error": null, "method": "local"}
{"id": "patient_01_q4", "query": "Which therapy regime does the oncology board recommend for Mrs. Sample?", "options_scores": {"A": 4.8617143630981445, "B": 4.922186851501465, "C": 4.352514743804932, "D": 0.8758242130279541, "E": 4.525217533111572}, "ranked_options": [{"letter": "D", "text": "6 cycles of R-Pola-CHP", "avg_nll": 0.8758242130279541}, {"letter": "C", "text": "6 cycles of L-Pola-CRP", "avg_nll": 4.352514743804932}, {"letter": "E", "text": "8 cycles of M-Pola-CHZ", "avg_nll": 4.525217533111572}, {"letter": "A", "text": "5 cycles of T-Pola-RHP", "avg_nll": 4.8617143630981445}, {"letter": "B", "text": "7 cycles of R-Luna-CHT", "avg_nll": 4.922186851501465}], "correct_answer_letter": "D", "error": null, "method": "local"}
{"id": "patient_01_q5", "query": "Mrs. Sample has bone metastasis, of which one was surgically addressed. Where was this metastasis located? ", "options_scores": {"A": 2.9161171913146973, "B": 3.0634236335754395, "C": 0.7488691210746765, "D": 1.82569420337677, "E": 2.5372774600982666}, "ranked_options": [{"letter": "C", "text": "Thoracic vertebra 10", "avg_nll": 0.7488691210746765}, {"letter": "D", "text": "Thoracic vertebra 11", "avg_nll": 1.82569420337677}, {"letter": "E", "text": "Thoracic vertebra 12", "avg_nll": 2.5372774600982666}, {"letter": "A", "text": "Thoracic vertebra 8", "avg_nll": 2.9161171913146973}, {"letter": "B", "text": "Thoracic vertebra 9", "avg_nll": 3.0634236335754395}], "correct_answer_letter": "C", "error": null, "method": "local"}
{"id": "patient_01_q6", "query": "On 01/09/2017, Mrs. Sample received a CT scan of her whole body. What kind of contrast agent was used?", "options_scores": {"A": 1.8080273866653442, "B": 3.5638792514801025, "C": 2.6554529666900635, "D": 7.153610706329346, "E": 1.1640371084213257}, "ranked_options": [{"letter": "E", "text": "Xenetix 350", "avg_nll": 1.1640371084213257}, {"letter": "A", "text": "Omnipaque 320", "avg_nll": 1.8080273866653442}, {"letter": "C", "text": "Optiray 320", "avg_nll": 2.6554529666900635}, {"letter": "B", "text": "Imeron 400", "avg_nll": 3.5638792514801025}, {"letter": "D", "text": "Gadovist", "avg_nll": 7.153610706329346}], "correct_answer_letter": "A", "error": null, "method": "local"}
{"id": "patient_01_q7", "query": "Mrs. Sample received multiple radiologic examinations. In which order did she receive them?", "options_scores": {"A": 3.0024733543395996, "B": 2.0338940620422363, "C": 3.3585140705108643, "D": 3.344890594482422, "E": 2.8801660537719727}, "ranked_options": [{"letter": "B", "text": "MR Brain > MR thoracic/lumbar spine > CT chest/abdomen/pelvis > CT Thoracic Spine > CT Thoracic Spine > CT chest/abdomen/pelvis > Abdominal ultrasound > MR Spine > Whole-body PET/CT > Liver MRI", "avg_nll": 2.0338940620422363}, {"letter": "E", "text": "CT Thoracic Spine > CT Whole Body > MR cervical spine > MR Head", "avg_nll": 2.8801660537719727}, {"letter": "A", "text": "MR spine > MR Head > CT Thoracic Spine > CT Whole Body", "avg_nll": 3.0024733543395996}, {"letter": "D", "text": "MR Brain > CT Thoracic Spine > MR cervical spine > CT Whole Body", "avg_nll": 3.344890594482422}, {"letter": "C", "text": "MR cervical spine > MR Head > CT Whole Body > CT Thoracic Spine", "avg_nll": 3.3585140705108643}], "correct_answer_letter": "B", "error": null, "method": "local"}
{"id": "patient_01_q8", "query": "Mrs. Sample’ medications changed between admission and discharge. Which of the following statements is correct?", "options_scores": {"A": 1.2322818040847778, "B": 2.5012917518615723, "C": 0.9768108129501343, "D": 2.5778896808624268, "E": 2.7196309566497803}, "ranked_options": [{"letter": "C", "text": "The dose of Sertraline hydrochloride was increased from 50 mg to 100 mg.", "avg_nll": 0.9768108129501343}, {"letter": "A", "text": "Aspirin was discontinued.", "avg_nll": 1.2322818040847778}, {"letter": "B", "text": "The patient started taking Pregabalin 50 mg, 1-0-0-0", "avg_nll": 2.5012917518615723}, {"letter": "D", "text": "The patient started taking prednisolone and is recommended to continue taking it for the rest of her life.", "avg_nll": 2.5778896808624268}, {"letter": "E", "text": "The patient started taking 2mg of Melatonin in the evening.", "avg_nll": 2.7196309566497803}], "correct_answer_letter": "E", "error": null, "method": "local"}
{"id": "patient_01_q9", "query": "Based on the medication changes from admission to discharge, which of the following best describes the Mrs Sample's evolving clinical situation?", "options_scores": {"A": 2.622145891189575, "B": 1.5960729122161865, "C": 2.397038459777832, "D": 1.728253722190857, "E": 2.4256386756896973}, "ranked_options": [{"letter": "B", "text": "The patient's pain management was escalated, as indicated by an increased frequency of Hydromorphone intake.", "avg_nll": 1.5960729122161865}, {"letter": "D", "text": "The patient's mood disorder was deemed stabilized, leading to the discontinuation of Sertraline at discharge.", "avg_nll": 1.728253722190857}, {"letter": "C", "text": "The patient developed a new gastrointestinal issue, hence the introduction of Pantoprazole at discharge.", "avg_nll": 2.397038459777832}, {"letter": "E", "text": "The patient's immobility concerns were resolved, leading to the discontinuation of Enoxaparin sodium (Clexane®) at discharge.", "avg_nll": 2.4256386756896973}, {"letter": "A", "text": "The patient's cardiovascular risk was decreased, leading to a reduced number of cardiovascular medications at discharge.", "avg_nll": 2.622145891189575}], "correct_answer_letter": "B", "error": null, "method": "local"}
